Herbal cholesterol treatment gets a boost: higher dose tested in new trial
NCT ID NCT06822946
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This Phase II trial tests whether a higher dose of Zhibitai capsules (a traditional Chinese medicine) can lower LDL ('bad') cholesterol more effectively than the standard dose in people with primary hyperlipidemia. About 192 adults aged 18–75 with high LDL and normal-to-moderate triglycerides will take either two capsules or one capsule twice daily for 12 weeks. The main goal is to see how much LDL drops over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Zhibitai capsule (herbal medicine)
- What this could lead to
- If successful, this could offer a new, higher-dose option for managing high cholesterol with a traditional Chinese medicine.
- What could go wrong
- This is an early Phase II trial with only 192 participants, so results may not confirm effectiveness or safety. The herbal nature also means interactions and side effects are not fully known.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY HYPERLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Xiangya Second Hospital of Central South University
RECRUITINGChangsha, Hunan, 410000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.